Search

Your search keyword '"Standley, Dm"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Standley, Dm" Remove constraint Author: "Standley, Dm"
138 results on '"Standley, Dm"'

Search Results

1. Mapping circulating serum miRNAs to their immune-related target mRNAs

2. Modeling the alternative oxidase from the human pathogen Blastocystis using automated hybrid structural template assembly

Catalog

Books, media, physical & digital resources

3. Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation

6. Lonidamine, a Novel Modulator for the BvgAS System of Bordetella Species.

7. BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis.

8. Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients.

9. Robust detection of infectious disease, autoimmunity, and cancer from the paratope networks of adaptive immune receptors.

10. Regulation of lymphoid-myeloid lineage bias through regnase-1/3-mediated control of Nfkbiz.

11. Structural basis of Irgb6 inactivation by Toxoplasma gondii through the phosphorylation of switch I.

12. Deciphering the antigen specificities of antibodies by clustering their complementarity determining region sequences.

13. Enhancement of SARS-CoV-2 Infection via Crosslinking of Adjacent Spike Proteins by N-Terminal Domain-Targeting Antibodies.

14. Circadian ribosome profiling reveals a role for the Period2 upstream open reading frame in sleep.

15. Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity.

16. Bacterial induction of B cell senescence promotes age-related changes in the gut microbiota.

17. The ClusPro AbEMap web server for the prediction of antibody epitopes.

18. Intercellular crosstalk in adult dental pulp is mediated by heparin-binding growth factors Pleiotrophin and Midkine.

19. Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex.

20. Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease.

21. Mapping of antibody epitopes based on docking and homology modeling.

22. Structural Modeling of Adaptive Immune Responses to Infection.

23. The evolution of structural genomics.

24. Advances in antibody discovery from human BCR repertoires.

25. Engineering ACE2 decoy receptors to combat viral escapability.

26. Improved Antibody-Specific Epitope Prediction Using AlphaFold and AbAdapt.

27. The protein-stabilizing effects of TMAO in aqueous and non-aqueous conditions.

28. An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo.

29. Cyclin J-CDK complexes limit innate immune responses by reducing proinflammatory changes in macrophage metabolism.

30. Unbiased integration of single cell transcriptome replicates.

31. AbAdapt: an adaptive approach to predicting antibody-antigen complex structures from sequence.

32. High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD).

33. Landscape of infection enhancing antibodies in COVID-19 and healthy donors.

34. Structural basis of membrane recognition of Toxoplasma gondii vacuole by Irgb6.

35. Emerging SARS-CoV-2 variants follow a historical pattern recorded in outgroups infecting non-human hosts.

36. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.

37. Hepatitis C virus modulates signal peptide peptidase to alter host protein processing.

38. Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells.

39. Analysis of Protein Intermolecular Interactions with MAFFT-DASH.

40. Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution.

41. Methods for sequence and structural analysis of B and T cell receptor repertoires.

42. Various miRNAs compensate the role of miR-122 on HCV replication.

43. Impact and relevance of alcohol dehydrogenase enantioselectivities on biotechnological applications.

44. Noncanonical STAT1 phosphorylation expands its transcriptional activity into promoting LPS-induced IL-6 and IL-12p40 production.

45. Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis.

46. Initial phospholipid-dependent Irgb6 targeting to Toxoplasma gondii vacuoles mediates host defense.

47. Reversible control of enantioselectivity by the length of ketone substituent in biocatalytic reduction.

48. Structural basis for a highly (S)-enantioselective reductase towards aliphatic ketones with only one carbon difference between side chain.

50. Translation-dependent unwinding of stem-loops by UPF1 licenses Regnase-1 to degrade inflammatory mRNAs.